INT285712

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.23
First Reported 2008
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 3
Total Number 3
Disease Relevance 2.01
Pain Relevance 1.09

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cytosol (Set) nucleoplasm (Set) endoplasmic reticulum (Set)
nucleus (Set) protein complex (Set) cytoplasm (Set)
Anatomy Link Frequency
liver 1
Set (Rattus norvegicus)
Pain Link Frequency Relevance Heat
backache 132 99.80 Very High Very High Very High
Lasting pain 2 94.72 High High
ischemia 12 57.84 Quite High
Inflammation 36 51.08 Quite High
cytokine 15 5.00 Very Low Very Low Very Low
Pain 12 5.00 Very Low Very Low Very Low
Inflammatory response 6 5.00 Very Low Very Low Very Low
Sciatica 6 5.00 Very Low Very Low Very Low
Inflammatory mediators 2 5.00 Very Low Very Low Very Low
spinal stenosis 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Low Back Pain 134 99.80 Very High Very High Very High
Cognitive Disorder 8 95.68 Very High Very High Very High
Pain 14 94.72 High High
Injury 12 93.60 High High
Apoptosis 42 78.80 Quite High
Hepatotoxicity 3 65.56 Quite High
Death 3 59.84 Quite High
Reperfusion Injury 8 58.60 Quite High
INFLAMMATION 43 51.08 Quite High
Chronic Disease 2 49.32 Quite Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
These aspects should therefore be taken into consideration in a revised Comprehensive ICF Core Set.
Localization (revised) of Set
1) Confidence 0.23 Published 2008 Journal Patient preference and adherence Section Body Doc Link PMC2770393 Disease Relevance 0.97 Pain Relevance 0.70
All these considerations also apply to the validation of this ICF Core Set for LBP.
Localization (validation) of Set associated with backache
2) Confidence 0.23 Published 2008 Journal Patient preference and adherence Section Body Doc Link PMC2770393 Disease Relevance 0.34 Pain Relevance 0.34
Importantly, treatment with an inactive form of CORM-2 (iCORM-2), incapable of releasing CO, did not reduce liver I/Ri, indicating that release of CO is important for therapeutic activity (Fig. 1C).
Localization (releasing) of iCORM-2 in liver
3) Confidence 0.01 Published 2010 Journal BMC Gastroenterol Section Body Doc Link PMC2873601 Disease Relevance 0.70 Pain Relevance 0.05

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox